Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Status:
Completed
Trial end date:
2017-05-19
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia, Europe and the United States of America (USA). The aim of
the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on
to metformin in subjects with type 2 diabetes.